Volume | 0 |
|
|||||
News | - |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Revelation Biosciences Inc | REVBW | NASDAQ | Equity Warrant |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.0178 |
Trades | Volume | Avg Volume |
---|---|---|
0 | 0 | - |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | 0.0178 | USD |
Revelation Biosciences Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
112.09k | 6.30M | - | 0 | -120k | -0.02 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Revelation Biosciences
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
REVBW Historical
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. It has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2, including its variants, influenza A and B, parainfluenza, rhinovirus, and RSV. REVTx-99 is also being developed for other indications such as: allergic rhinitis and chronic nasal congestion. REVTx-200 is an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. REVTx-200 is based on the same technology used in REVTx-99. |
REVBW -
What is the current Revelation Biosciences Inc share price?
The current share price of Revelation Biosciences Inc is $ 0.0178
How many Revelation Biosciences Inc shares are in issue?
Revelation Biosciences Inc has 6,297,000 shares in issue
What is the market cap of Revelation Biosciences Inc?
The market capitalisation of Revelation Biosciences Inc is USD 112.09k
What is the 1 year trading range for Revelation Biosciences Inc share price?
Revelation Biosciences Inc has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Revelation Biosciences Inc?
The price to earnings ratio of Revelation Biosciences Inc is -1.05
What is the reporting currency for Revelation Biosciences Inc?
Revelation Biosciences Inc reports financial results in USD
What is the latest annual profit for Revelation Biosciences Inc?
The latest annual profit of Revelation Biosciences Inc is USD -120k
What is the registered address of Revelation Biosciences Inc?
The registered address for Revelation Biosciences Inc is 16192 COASTAL HWY, LEWES, DELAWARE, 19958
Which industry sector does Revelation Biosciences Inc operate in?
Revelation Biosciences Inc operates in the BLANK CHECKS sector